Nurse Practitioner · Charleston, SC
NPI
1275667164
Since 2007
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
171 Ashley Ave
Charleston, SC, 29425
Phone (843) 792-1414
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
208 services
Medicare patients, 2024
108
Average age 74
Drug cost, 2024
$4.4M
471 prescriptions
Company payments, 2024
$702
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura Milligan was code 99214 (office e&m - established), 127 times for 68 patients. In total Laura Milligan billed 208 services in 15 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 127 | 68 | $53.42 | $6,784 |
| 99213 Office E&M - Established | Facility | 33 | 31 | $34.93 | $1,153 |
By year: 2022 $54K for 2,336 services; 2023 $149K for 6,037 services; 2024 $10K for 208 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laura Milligan prescribed most often to Medicare patients was Acyclovir, with 109 prescriptions and refills. In total Laura Milligan wrote 471 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 109 | 156 | 26 | $1,916 |
| Revlimid Lenalidomide | 76 | 76 | 20 | $1.3M |
| Iclusig Ponatinib Hcl | 20 | 20 | Under 11 | $396K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 17 | 30 | Under 11 | $107 |
| Hydroxyurea Generic | 16 | 25 | Under 11 | $297 |
| Allopurinol Generic | 15 | 21 | Under 11 | $80.08 |
| Eliquis Apixaban | 15 | 15 | Under 11 | $6,528 |
| Scemblix Asciminib Hydrochloride | 14 | 14 | Under 11 | $1.0M |
| Budesonide Dr Budesonide | 13 | 13 | Under 11 | $658 |
| Tibsovo Ivosidenib | 12 | 12 | Under 11 | $345K |
| Bosulif Bosutinib | 12 | 12 | Under 11 | $237K |
| Pomalyst Pomalidomide | 12 | 12 | Under 11 | $245K |
Brand drugs: 220 claims; generic drugs: 251 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Laura Milligan $702 ($702 in general payments such as food, travel and fees) from 3 companies. The largest payer was Blueprint Medicines Corporation with $546.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.